Inactive Instrument
PREDILIFE Stock Euronext Paris
Stocks
ALPRE
FR0010169920
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - | - |
|
| 06-28 | Predilife S.A. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 02-09 | Intégrance Launches Preventive Health Program for Employees |
| Market Cap | 5.41M 6.26M 6.26M 5.09M 4.62M 8.7M 600M 8.82M 59.67M 23.38M 300M 23.5M 22.99M 999M | P/E 2024 |
-3.18x | P/E 2025 | -3.01x |
|---|---|---|---|---|---|
| Enterprise Value | 10.18M 11.79M 11.79M 9.58M 8.71M 16.38M 1.13B 16.62M 112M 44.05M 565M 44.27M 43.31M 1.88B | EV / Sales 2024 |
34.5x | EV / Sales 2025 | 19.3x |
| Free-Float |
48.75% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Stéphane Ragusa
CEO | Chief Executive Officer | 56 | 2003-12-31 |
Émilien Gauthier
CTO | Chief Tech/Sci/R&D Officer | - | 2006-12-31 |
Marion Renelier
LAW | General Counsel | - | 2015-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Stéphane Ragusa
CHM | Chairman | 56 | 2003-12-31 |
Charles Vilgrain
BRD | Director/Board Member | 46 | 2017-12-31 |
Antoine Bricard
BRD | Director/Board Member | 58 | 2017-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.85% | -3.27% | +97.90% | +294.86% | 3.92B | ||
| -3.33% | -12.35% | +35.28% | +64.10% | 3.27B | ||
| -0.99% | +8.32% | +181.20% | +15.82% | 3.18B | ||
| -0.43% | -2.22% | +289.70% | +449.11% | 2.39B | ||
| -1.68% | -5.23% | -25.35% | -27.61% | 2.23B | ||
| -0.43% | -3.67% | +9.37% | - | 1.52B | ||
| -5.75% | -6.91% | +7.83% | +44.98% | 977M | ||
| +1.06% | -1.20% | +123.35% | -43.22% | 855M | ||
| -11.56% | -1.10% | +8.62% | +270.60% | 545M | ||
| Average | -2.66% | -2.48% | +80.88% | +133.58% | 2.1B | |
| Weighted average by Cap. | -1.79% | -2.54% | +97.64% | +148.65% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 493K 571K 571K 464K 422K 793K 54.71M 805K 5.44M 2.13M 27.36M 2.14M 2.1M 91.15M | 836K 968K 968K 786K 715K 1.34M 92.72M 1.36M 9.22M 3.62M 46.37M 3.63M 3.55M 154M |
| Net income | -4.26M -4.94M -4.94M -4.01M -3.65M -6.86M -473M -6.96M -47.07M -18.45M -237M -18.54M -18.14M -788M | -3.93M -4.56M -4.56M -3.7M -3.36M -6.33M -436M -6.42M -43.42M -17.02M -218M -17.1M -16.73M -727M |
| Net Debt | 3.54M 4.1M 4.1M 3.33M 3.03M 5.69M 393M 5.77M 39.05M 15.3M 196M 15.38M 15.05M 654M | 4.78M 5.53M 5.53M 4.5M 4.09M 7.68M 530M 7.8M 52.73M 20.66M 265M 20.77M 20.32M 883M |
Employees
-
- Stock Market
- Stocks
- ALPRE Stock
- ALPRE Stock
Select your edition
All financial news and data tailored to specific country editions
















